Next Article in Journal
Association between Sarcopenic Obesity, Type 2 Diabetes, and Hypertension in Overweight and Obese Treatment-Seeking Adult Women
Previous Article in Journal
Defective Vagal Innervation in Murine Tbx1 Mutant Hearts
Article Menu

Export Article

Open AccessReview
J. Cardiovasc. Dev. Dis. 2018, 5(4), 50; https://doi.org/10.3390/jcdd5040050

Gene Therapy Approaches to Biological Pacemakers

1
Centre for Heart Research, the Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW 2145, Australia
2
Sydney Medical School, The University of Sydney, Sydney, NSW 2006, Australia
3
Department of Cardiology, Westmead Hospital, Westmead, NSW 2145, Australia
4
Departments of Pediatrics and Biomedical Engineering, Emory University, Atlanta, GA 30322, USA
*
Author to whom correspondence should be addressed.
Received: 28 September 2018 / Revised: 16 October 2018 / Accepted: 17 October 2018 / Published: 19 October 2018
(This article belongs to the Special Issue Cardiaovascular Gene Therapy)
Full-Text   |   PDF [653 KB, uploaded 19 October 2018]   |  

Abstract

Bradycardia arising from pacemaker dysfunction can be debilitating and life threatening. Electronic pacemakers serve as effective treatment options for pacemaker dysfunction. They however present their own limitations and complications. This has motivated research into discovering more effective and innovative ways to treat pacemaker dysfunction. Gene therapy is being explored for its potential to treat various cardiac conditions including cardiac arrhythmias. Gene transfer vectors with increasing transduction efficiency and biosafety have been developed and trialed for cardiovascular disease treatment. With an improved understanding of the molecular mechanisms driving pacemaker development, several gene therapy targets have been identified to generate the phenotypic changes required to correct pacemaker dysfunction. This review will discuss the gene therapy vectors in use today along with methods for their delivery. Furthermore, it will evaluate several gene therapy strategies attempting to restore biological pacing, having the potential to emerge as viable therapies for pacemaker dysfunction. View Full-Text
Keywords: atrioventricular node; bradycardia; gene therapy; heart; pacemaker; sinoatrial node; viral vector atrioventricular node; bradycardia; gene therapy; heart; pacemaker; sinoatrial node; viral vector
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Farraha, M.; Kumar, S.; Chong, J.; Cho, H.C.; Kizana, E. Gene Therapy Approaches to Biological Pacemakers. J. Cardiovasc. Dev. Dis. 2018, 5, 50.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Cardiovasc. Dev. Dis. EISSN 2308-3425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top